Italian consensus on treatment of spasticity in multiple sclerosis

Effects on Spasticity and Neuropathic Pain of an Oral Formulation of Δ9-tetrahydrocannabinol in Patients WithProgressive Multiple Sclerosis

(2017) Guido van Amerongen et al.   CLINICAL THERAPEUTICS

Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper

(2016) Susana Otero-Romero et al.   Multiple Sclerosis Journal

Improvement of spasticity following intermittent theta burst stimulation in multiple sclerosis is associated with modulation of resting-state functional connectivity of the primary motor cortices

(2016) Clémence Boutière et al.   Multiple Sclerosis Journal

Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper

(2016) Susana Otero-Romero et al.   Multiple Sclerosis Journal

Improvement of spasticity following intermittent theta burst stimulation in multiple sclerosis is associated with modulation of resting-state functional connectivity of the primary motor cortices

(2016) Clémence Boutière et al.   Multiple Sclerosis Journal

Spasticity in multiple sclerosis: Associations with impairments and overall quality of life

(2016) K. Milinis et al.   Multiple Sclerosis and Related Disorders

Effect of slow release-Fampridine on muscle strength, rate of force development, functional capacity and cognitive function in an enriched population of MS patients. A randomized, double blind, placebo controlled study

(2016) H.B. Jensen et al.   Multiple Sclerosis and Related Disorders

The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis

(2015) Susan Ball et al.   HEALTH TECHNOLOGY ASSESSMENT

Sativex® and clinical–neurophysiological measures of spasticity in progressive multiple sclerosis

(2015) Letizia Leocani et al.   JOURNAL OF NEUROLOGY

Anodal transcranial direct current stimulation of motor cortex does not ameliorate spasticity in multiple sclerosis

(2015) Rosa Iodice et al.   RESTORATIVE NEUROLOGY AND NEUROSCIENCE

Does giving segmental muscle vibration alter the response to botulinum toxin injections in the treatment of spasticity in people with multiple sclerosis? A single-blind randomized controlled trial

(2013) Marco Paoloni et al.   CLINICAL REHABILITATION

Guidance for the preparation of neurological management guidelines by EFNS scientific task forces - revised recommendations 2012

(2013) M. A. Leone et al.   EUROPEAN JOURNAL OF NEUROLOGY

Comparison of the effect of baclofen and transcutaneous electrical nerve stimulation for the treatment of spasticity in multiple sclerosis

(2013) Vahid Shaygannejad et al.   NEUROLOGICAL RESEARCH

MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial

(2012) John Peter Zajicek et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis

(2011) A. Novotna et al.   EUROPEAN JOURNAL OF NEUROLOGY

GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables

(2011) Gordon Guyatt et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis

(2011) Francesco Mori et al.   JOURNAL OF NEUROLOGY

A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols)

(2011) W Notcutt et al.   Multiple Sclerosis Journal

Physiological Basis of Transcranial Direct Current Stimulation

(2011) Charlotte J. Stagg et al.   NEUROSCIENTIST

A DOUBLE-BLIND TRIAL WITH BACLOFEN (LIORESAL®) AND DIAZEPAM IN SPASTICITY DUE TO MULTIPLE SCLEROSIS

(2010) Arne From et al.   ACTA NEUROLOGICA SCANDINAVICA

Nightly Sublingual Tizanidine HCl in Multiple Sclerosis

(2010) Veronika Vakhapova et al.   CLINICAL NEUROPHARMACOLOGY

A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis

(2010) C. Collin et al.   NEUROLOGICAL RESEARCH

Effects of intermittent theta burst stimulation on spasticity in patients with multiple sclerosis

(2009) F. Mori et al.   EUROPEAN JOURNAL OF NEUROLOGY

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE